Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Eva Fernandez1, Raul Perez, Alfredo Hernandez

  • 1Department of Pharmacy, Getafe University Hospital, Carretera Toledo Km 12,5 Getafe, Madrid, Spain. efernandeze.hugf@salud.madrid.org.

Pharmaceutics
|December 7, 2013
PubMed

Insights

Pediatric drug pharmacokinetics and pharmacodynamics differ significantly from adults due to age-related physiological variations affecting absorption, distribution, metabolism, and excretion. Understanding these pediatric-specific changes is crucial for safe and effective medication use in children.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Metabolism

Background:

  • Physiologic differences between children and adults impact drug behavior.
  • Age-related changes in pharmacokinetics and pharmacodynamics are well-documented.
  • Pediatric drug development requires understanding unique physiological characteristics.

Purpose of the Study:

  • To elucidate age-related differences in drug pharmacokinetics and pharmacodynamics.
  • To highlight key factors influencing drug bioavailability, distribution, metabolism, and excretion in pediatric populations.
  • To emphasize the importance of considering pediatric-specific physiological parameters in drug therapy.

Main Methods:

  • Comparative analysis of physiological factors influencing drug disposition in pediatric and adult populations.
  • Review of anatomical, physiological, and biochemical characteristics affecting drug absorption and distribution.
  • Examination of developmental changes in drug metabolism and excretion pathways.

Main Results:

  • Oral bioavailability is influenced by gastric pH, emptying time, and intestinal transit in children.
  • Drug distribution differs due to variations in membrane permeability, protein binding, and body water.
  • Significant differences exist in Phase I and II drug metabolism enzymes between pediatric and adult populations.
  • Renal excretion is affected by the immaturity and maturation of glomerular filtration and tubular functions in neonates and children.

Conclusions:

  • Age-specific physiological differences profoundly affect drug pharmacokinetics and pharmacodynamics in children.
  • Understanding these differences is essential for optimizing pediatric drug therapy and ensuring patient safety.
  • Further research into pediatric pharmacology is vital for advancing evidence-based medicine for children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K